How many institutions held CARA - Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share in Q1 2020?

130 institutional investors reported CARA - Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share for Q1 2020. Use the holders table for investor-level position and value details.

Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA)

Q: What does CUSIP 140755109 represent in this 13F holders report?

CUSIP 140755109 is the security identifier for CARA - Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 140755109

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 54,790,889
Total 13F shares: 32,217,643
Share change: +918,444
Total reported value: $425,460,027
Put/Call ratio: 57%
Price per share: $13.21
Number of holders: 130
Value change: +$9,271,004
Number of buys: 50
Number of sells: 73

Quarterly Holders Quick Answers

What is CUSIP 140755109?
CUSIP 140755109 identifies CARA - Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2020
Previous quarter: Q4 2019

Recent filing periods for CUSIP 140755109:

Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023

Institutional Holders of Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) as of Q1 2020

As of 31 Mar 2020, Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) was held by 130 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 32,217,643 shares. The largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., RHO CAPITAL PARTNERS INC, FARALLON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, Carmignac Gestion, FIRST MANHATTAN CO, Chescapmanager LLC, STATE STREET CORP, and BANK OF AMERICA CORP /DE/. This page lists 130 institutional shareholders reporting positions in this security for the Q1 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.